Panagora Asset Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Panagora Asset Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-395	Closed	-$14K	–	3017
2020 Q3	$14K	Buy	395 +280	+243%	+$12.2K	﹤0.01%	2276
2020 Q2	$5K	Hold	115	–	–	﹤0.01%	2367
2020 Q1	$9K	Buy	+115	New	+$9.2K	﹤0.01%	2165
2019 Q2	–	Sell	-866	Closed	-$45K	–	2704
2019 Q1	$45K	Sell	866 -513	-37%	-$27.8K	﹤0.01%	2069
2018 Q4	$87K	Sell	1,379 -424	-24%	-$23.3K	﹤0.01%	1844
2018 Q3	$110K	Sell	1,803 -551	-23%	-$23.9K	﹤0.01%	1827
2018 Q2	$96K	Buy	2,354 +1,943	+473%	+$153K	﹤0.01%	1861
2018 Q1	$39K	Buy	+411	New	+$52.7K	﹤0.01%	2102

Other funds holding EVFM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TWMP

Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

Panagora Asset Management's EVFM Position: Q4 2020 in Review

Panagora Asset Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2020, closing a stake of 395 shares — an estimated $14K sold.

Panagora Asset Management first reported a position in EVFM in Q1 2018 and held it in 8 quarters. The position peaked at $110K in Q3 2018. 93 funds tracked by Wall St. Rank hold EVFM as of Q4 2020.

Panagora Asset Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Panagora Asset Management sold 395 Evofem Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $14K.
Panagora Asset Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2018 and held it in 8 quarters.
Panagora Asset Management's Evofem Biosciences, Inc. Common Stock position peaked at $110K in Q3 2018.
93 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2020.

Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.